请输入您要查询的百科知识:

 

词条 Technetium (99mTc) medronic acid
释义

  1. Chemistry

  2. Manufacture

  3. References

{{DISPLAYTITLE:Technetium (99mTc) medronic acid}}{{Drugbox
| verifiedrevid = 447758776
| IUPAC_name = Methylenebis(phosphonic acid) technetium (99mTc)
| image = Tc-99m medronic acid skeletal.svg
| drug_name = Technetium (99mTc) medronic acid
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration = intravenous
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number =
| CAS_supplemental =
| ATC_prefix = V09
| ATC_suffix = BA02
| ATC_supplemental =
| PubChem = 157443
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| chemical_formula = CH6O6P2 • x99mTc
| molecular_weight = unknown
| synonyms =
}}Technetium (99mTc) medronic acid is a pharmaceutical product used in nuclear medicine to localize bone metastases[1] as well as other diseases that can alter the natural turn-over in the bone by bone scintigraphy.[2]

Chemistry

The drug is a complex of medronic acid, (MDP, methylene diphosphonate), the simplest bisphosphonate, with technetium-99m (99mTc), a radionuclide that emits gamma rays. The exact structure of the complex is not known.[2][3]

Manufacture

99mTc-MDP must be prepared in a radiopharmacy. It is usually supplied as a "cold kit" to which radioactive 99mTc from a generator is added. Kit composition may vary between suppliers, but contents typically includes medronic acid, stannous chloride dihydrate and sometimes ascorbic acid.[4] Pertechnetate, eluted from the generator is added to the kit vial, which is swirled and left to stand. The labelling efficiency, an indication of how much 99mTc remains in pertechnetate form rather than bound to the MDP, can be measured using chromatography.[5][6][7][8]

References

1. ^{{cite journal| pmid=15788608 | doi=10.2214/ajr.184.4.01841266 | volume=184 | issue=4 | title=Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer | year=2005 | journal=AJR Am J Roentgenol | pages=1266–73 | last1 = Uematsu | first1 = T | last2 = Yuen | first2 = S | last3 = Yukisawa | first3 = S | last4 = Aramaki | first4 = T | last5 = Morimoto | first5 = N | last6 = Endo | first6 = M | last7 = Furukawa | first7 = H | last8 = Uchida | first8 = Y | last9 = Watanabe | first9 = J}}
2. ^FDA Label: MDP Multidose Utilipack
3. ^KEGG Drug: D02029
4. ^{{cite web|title=List of labelling kits for the preparation of a technetium-99m labelled bone scanning agent|url=https://humanhealth.iaea.org/HHW/Radiopharmacy/VirRad/Selection_of_Labelling_Kit/List_of_labelling_kits/index.html|website=Human Health Campus|publisher=IAEA|accessdate=3 March 2017}}
5. ^{{cite web|title=MDP Bracco|url=http://www.nuclearonline.org/PI/BRACCO%20MDP%20doc.pdf|publisher=Bracco Diagnostics|accessdate=3 March 2017}}
6. ^{{cite web|title=Kit for the Preparation of Technetium Tc 99m Medronate for Injection|url=http://www.pharmalucence.com/images/MedronateInsert.pdf|publisher=Pharmalucence|accessdate=3 March 2017}}
7. ^{{cite web|title=TechneScan MDP Kit for the Preparation of Technetium Tc 99m Medronate Package Insert|url=http://www.nuclearonline.org/PI/Mallicknrodt%20MDP.pdf|publisher=Mallinckrodt Medical|accessdate=3 March 2017}}
8. ^{{cite journal|last1=Mather|first1=SJ|last2=Ellison|first2=D|title=Reduction-mediated technetium-99m labeling of monoclonal antibodies.|journal=Journal of Nuclear Medicine|date=May 1990|volume=31|issue=5|pages=692–7|pmid=2341907|url=http://jnm.snmjournals.org/content/31/5/692.long}}
{{Radiopharmaceuticals}}{{pharma-stub}}

2 : Bisphosphonates|Technetium-99m

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/30 18:29:23